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ABSTRACT
The effects of estrogen and progesterone on the function of chick oviduct tubular gland
cells have been studied. Such function, as measured by the increase in specific cell products
such as lysozyme and ovalbumin, requires the continuous presence of estrogen or proges-
terone. Withdrawal of hormone results in a rapid cessation of function and an involution
of the oviduct accompanied by rapid decreases in total weight, lysozyme, and RNA . During
such involution, tubular gland cells per se persist, as evidenced by a lack of comparable de-
crease in total DNA content and by histological demonstration of tubular gland cells. When
estrogen administration is reinstituted, preexisting tubular gland cells rapidly synthesize
ovalbumin and lysozyme without requiring new DNA synthesis . Administration of proges-
terone also stimulates the function of such cells. Furthermore, the effects of estrogen and
progesterone are synergistic on the synthesis of lysozyme and ovalbumin, whereas proges-
terone antagonizes the estrogen-evoked formation of tubular gland cells. It is suggested
that such complex interactions of estrogen and progesterone on oviduct development and
function result from differences in responsiveness of the various cell types present in the
tissue.
INTRODUCTION
Studies from several laboratories have shown that
administration of estrogen to immature female
chicks elicits characteristic responses in the oviduct
including cell proliferation, cytodifferentiation,
and the synthesis of specific cell products such as
lysozyme and ovalbumin by tubular gland cells
(1-6). The interaction of estrogen and pro-
gesterone in oviduct development and function
appears to be complex. O'Malley and his co-
workers have studied extensively the initiation of
avidin synthesis by progesterone in epithelial
goblet cells in the oviduct of estrogen-primed
chicks (7-11). Recently we have reported a very
different effect of progesterone, namely that the
effect of estrogen to elicit the formation of tubular
gland cells is antagonized by concomitant ad-
ministration of progesterone (5, 6) . We also found
that once tubular gland cells are formed, proges-
123terone does not prevent the subsequent function
of this cell type.
In this paper, we have examined further the
interaction of estrogen and progesterone in the
oviduct, focusing mainly on their effects on tubular
gland cell function once such cells exist. We find
that the maintenance of such function requires
the continuous presence of estrogen, as determined
by the presence of lysozyme and ovalbumin . A
similar finding has been reported by O'Malley
et al. (2). Withdrawal of estrogen results in a
cessation of function and an involution of the
oviduct, although tubular gland cells persist .
When estrogen administration is reinstituted, such
preexisting cells rapidly synthesize lysozyme and
ovalbumin without requiring new DNA synthesis .
Most striking is the finding that the function of
such cells can also be stimulated by progesterone
which evokes little response in the immature ovi-
duct. Furthermore, the effects of estrogen and
progesterone appear to be synergistic, in contrast
to their effects on the formation of tubular gland
cells. These results, then, indicate that effects of
estrogen and progesterone are complex and differ
according to the cell type present during different
stages of oviduct development.
MATERIALS AND METHODS
Hormones and Chemicals
Progesterone, testosterone, androstanedione, and
hydrocortisone 21-phosphate were obtained from Nu-
tritional Biochemicals Corporation, Cleveland, Ohio .
Estradiol 17j&-benzoate was kindly provided by
Schering Corp., Bloomfield, N.J. Deoxycorticosterone
was obtained from Ciba Pharmaceutical Co., Sum-
mit, N.J. Medroxyprogesterone acetate was pur-
chased from The Upjohn Co., Kalamazoo, Mich .
Norethindrone was purchased from Parke, Davis &
Co., Detroit, Mich. Ribose, deoxyribose, and hy-
droxyurea were obtained from Calbiochem, Los
Angeles, Calif.
Treatment of Animals
Newborn white leghorn female chicks were ob-
tained from Kimber Farms, Fremont, Calif. Chicks
were maintained in electrically heated brooders and
fed a Purina Laboratory chow (micromixed) diet
(Ralston Purina Co., St. Louis, Mo.) throughout the
experiments. Chicks weighed about 50 g at 4 days
and 250 g at 26 days after birth . At ages indicated in
legends of the figures the chicks were given hormone
injections into the muscle mass of the hind limb below
the knee. Hormones were dissolved in sesame oil with 1 Specific activity.
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the exception of hydrocortisone 21-phosphate and
medroxyprogesterone which were dissolved in 0.15 M
NaCl. Each hormone was injected in a volume of
0.1 ml per chick.
Assays
The magnum portion of oviduct was removed,
weighed, and homogenized in a motor-driven glass
homogenizer with 9 volumes (w/v) of ice-cold
distilled water. DNA and RNA were extracted from
the homogenate by the method of Schneider (12).
DNA was assayed by the diphenylamine reaction
with deoxyribose as standard (13), and RNA was
assayed by the orcinol method with ribose as standard
(14) . Protein was estimated by the method of Lowry
et al. (15) with crystalline bovine serum albumin as
standard. Lysozyme was assayed by a modification
of the method of Litwack (16). Activity was measured
by continuous recording of the decrease in absorbancy
at 645 mµ at 25°C with Micrococcus lysodeikticus as
substrate with a Gilford Multiple Sample Absorbance
Recorder Model 2000 (Gilford Instrument Company,
Oberlin, Ohio) and a Beckman DU monochrometer
(Beckman Instruments Inc ., Fullerton, Calif.) . Ac-
tivity is expressed as micrograms of lysozyme present
and is based on the activity of purified egg white
lysozyme (Calbiochem) as standard.
Measurement of Extent of DNA Synthesis
The extent of DNA synthesis was estimated by the
incorporation of thymidine-3H into trichloroacetic
acid-insoluble material. Thymidine 3H (SA1 6.0
c/mmole, Schwarz Bio Research Inc ., Orangeburg,
N.Y.) was dissolved in 0.15 M NaCl and was injected
into the breast muscles at a dose of 5 gc per chick in
a volume of 0.1 ml. 30 min after the injection, the
magnum was removed and homogenized as described
above. An aliquot of homogenate was treated with an
equal volume of cold 10% trichloroacetic acid, and
the resulting precipitate was collected by centrifuga-
tion at 8000 g for 10 min at 2'. The pellet was washed
3 times with cold 5%o trichloroacetic acid, 2 times
with cold absolute ethanol, and 2 times with ether.
The final residue was dissolved in 1 ml of NCS solubi-
lizer (Nuclear-Chicago Corporation, Des Plaines, Ill.)
at 35°C overnight and then placed in a scintillation
vial for measurement of radioactivity. Treatment of
the tissue homogenate which had been obtained after
injection of thymidine 3H with DNase (Worthington
Biochemical Corp., Freehold, N.J.) at a concentration
of 100 ug/ml in 0.001 M potassium phosphate buffer,
pH 7.2, containing 0.001 M MgCl2 for 30 min at 37 °
converted 95% of trichloroacetic acid-insoluble radio-
activity into trichloroacetic acid-soluble material ;this indicates that the majority of thymidine 3H was
incorporated into DNA.
Measurement of Extent of
Ovalbumin Synthesis
Since it has been shown that laying-hen oviduct
minces synthesize ovalbumin in vitro at a rate
qualitatively, if not quantitatively, similar to that in
vivo (17), the extent of ovalbumin synthesis was
estimated as follows. The magnum was removed with
aseptic technique, placed in Hanks' salts solution
(GIBCO,2 Oakland, Calif.), and cut into small pieces
(1-2 mg wet weight each) . 20-25 tissue pieces were
placed in a Petri dish (5 cm diameter; Falcon Plastic,
Division of B-D Laboratories, Inc., Los Angeles,
Calif.) with 4 ml of Medium 199 (GIBCO, Oakland,
Calif.) modified to contain one-tenth the normal
concentration of lysine (0.7 µg/ml). Penicillin G and
streptomycin were added to a final concentration of
50 units/ml and 50 µg/ml, respectively . 15 min
after incubation, 4,5-lysine-3H (SA 291 c/mmole,
Nuclear-Chicago) was added to a final concentration
of 0.96 µc/ml, and incubations were continued . All
incubations were done at 37 °C in an atmosphere of
95% 02-5% CO2 with continuous shaking. 3 hr after
the addition of lysine- 3H, incubations were stopped
by cooling to 2°C and adding cyclohexamide and
sodium azide to a final concentration of 1 and 10 mss,
respectively. Tissues were blotted, weighed, and
homogenized in a motor-driven glass homogenizer
with 2 ml of 0.001 M potassium phosphate buffer,
pH 6.8, containing 1 DIM MgC12 . 2 ml of tissue
homogenates were sonicated for 5 see at 4°C with a
Sonifer Cell Disrupter (Heat Systems Co ., Melville,
N.Y.) at a setting of 2 with the microtip attachment,
then passed through glass wool to remove connective
tissues, and centrifuged at 105,000 g for 1 hr at 2 °.
To an aliquot of the 105,000 g supernatant was added
antiovalbumin or control gamma globulin prepared
as described previously (6) . Immunoprecipitation re-
actions were always carried out in the antibody-excess
region, and two different amounts of sample were
employed to insure the quantitative precipitation of
ovalbumin. After incubation at 37°C for 1 hr and
then at 4 ° for 24 hr, the antibody-antigen precipitate
was centrifuged and washed 3 times with 0 .01 M
potassium phosphate, pH 7 .2, containing 0 .15 M
NaCl. The washed precipitate was then dissolved in
1 ml of NCS at 37 ° overnight and placed in a scintil-
lation vial for measurement of radioactivity. In pre-
liminary studies,3 the rate of lysine-3H incorporation
2 Grand Island Biological Company, Division of
the Northamerican Mogul Product Co ., Grand
Island, N.Y.
3 T. Oka and R. T. Schimke. Unpublished observa-
tion.
into ovalbumin and total soluble protein was found
to be linear with time for 3-4 hr under the conditions
described above.
Radioactivity Measurements
Radioactivity was determined with a Packard
Model No. 3310 Liquid Scintillation Spectrometer
with a counting efficiencies of 28% for tritium and
750 /1 0 for carbon 14. Background was 25-29 cpm. The
scintillation fluid contained 4 g of 2,5-diphenyloxa-
zole and 0.4 g of 1 ,4-bis(2-(5-phenyloxazolyl))-
benzene (Packard Instrument Co., Inc., Downers
Grove, Ill.) in I liter of toluene, and 10 ml of toluene-
phosphor fluid was used in each vial.
Histological Procedures
Portions of magnum were fixed either in Bouin
fixative (18) or in 4% glutaraldehyde buffered with
0.01 M sodium phosphate buffer, pH 7.2 (19), for
24 hr at 25°C. The tissues were embedded in paraffin
after dehydration in a series of graded alcohol and
clearing in toluene. Sections of 7 µ thickness were
stained with Mayer's hematoxylin and eosin .
RESULTS
As shown in Fig. 1 a, daily administration of estro-
gen to immature female chicks markedly increases
oviduct wet weight. The rate of increase is minimal
in the first 2-3 days, reaches the maximum at 5-8
days, and thereafter gradually declines . Discon-
tinuation of estrogen administration at day 2 re-
sults in no appreciable increase in tissue weight
over the following period. Termination of estrogen
administration on day 5 results in a slower rate of
increase up to day 10, after which time tissue
weight declines rapidly . When estrogen adminis-
tration is discontinued on day 10, a rapid decrease
in wet weight occurs in the subsequent days. Sub-
stitution of progesterone administration for estro-
gen, starting on day 5, 8, or 10 of estrogen treat-
ment, results in a continued increase in wet weight
to almost the same or an even greater extent than
does estrogen administration .
Fig. 1 b shows changes in lysozyme content .
Lysozyme is localized in tubular gland cells (6),
and it can be used as a marker for the function of
these cells. After its first detection on day 3, lyso-
zyme content increases rapidly until day 10
following the daily administration of estrogen.
Thereafter, it continues to increase at a reduced
rate. When estrogen administration is discon-
tinued on day 2, the day prior to the first appear-
ance of lysozyme, no lysozyme is detected in the
subsequent days. Estrogen withdrawal on day 5
OKA AND ScxIMKE Hormone Interaction in Oviduct Development
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results in a slow, continued increase in lysozyme
content until day 10, following which a rapid de-
crease occurs. When estrogen administration is
stopped on day 10, there is a rapid decrease in
lysozyme content in the following 10 days . Pro-
gesterone, administered in place of estrogen
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FIGURES 1 a-d Changes in magnum: (a) wet weight, (b) lysozyme content, (c) total RNA content, and
(d) total DNA content. 4-day-old chicks were treated daily with a dose of 1 mg estradiol 17/3-benzoate/
chick (E) . At the indicated days, estrogen administration was either stopped (0	0), or chicks were
given progresterone (P) in place of estrogen daily at a dose of 1 mg/chick . Each point represents the
means f SEM of four chicks.
starting on day 5, 8, or 10, results in slightly
greater accumulation of lysozyme than does con-
tinued estrogen administration .
During daily administration of estrogen, total
RNA content increases continuously with the
maximal rate of increase between days 3 and 7(Fig. 1 c). Cessation of estrogen administration on
day 5 results in a continued increase in total RNA
for approximately 5 days, following which a rapid
decline commences. When estrogen administra-
tion is stopped on day 10, there is a rapid decline in
total RNA in the following period . Administration
of progesterone prevents the decrease in RNA con-
tent occurring after estrogen withdrawal.
In contrast to the rapid decreases in tissue wet
weight, lysozyme, and RNA content after with-
drawal of estrogen, changes in total DNA content
are somewhat different (Fig . 1 d). Thus, when
estrogen administration is discontinued on day
10, total DNA content decreases only 24% in the
following 12 days, whereas wet weight and lyso-
zyme and RNA content decrease 76, 91, and 82%,
respectively, in the same time period. These find-
ings suggest that the function of tubular gland
cells, as evidenced by changes in lysozyme and
RNA content, is continuously dependent on the
presence of hormone, whereas tubular gland cells
per se, as evidenced by the lack of comparable
change in total DNA content, remain in the tissue
after estrogen withdrawal. This suggestion is
substantiated by a comparison of the histological
appearance of the oviduct of chicks treated with
estrogen for 10 days with that of chicks treated
with estrogen for 10 days followed by 12 days of
estrogen withdrawal ("pretreated" chicks) .
As shown in Fig. 2 a, a 10 day treatment of im-
mature chicks with estrogen results in a marked
enlargement of the magnum with characteristic
tubular gland cells constituting the major portion
of the tissue. Such cells have been shown to con-
tain both lysozyme (6) and ovalbumin (20) .
Higher magnification of the area indicated in Fig.
2 a is shown in Fig. 2 b. These cells are literally en-
gorged with large numbers of eosinophilic granules
and form a characteristic acinar pattern with
peripherally placed nuclei which are widely sepa-
rated in the cells . Progesterone, administered in
place of estrogen from day 5 to day 10 (Fig. 1), re-
sults in a histological appearance of tubular gland
cells that is similar to that produced by a 10 day
estrogen treatment. As described by Kohler et al .
(4), ciliated cells and goblet cells with basally
placed nuclei are found in the epithelial layer of
the magnum of estrogen-treated chicks. In addi-
tion, progesterone administration appears to
enhance the changes in the epithelial layer in-
cluding more pronounced presence of goblet and
ciliated cells.
The histological appearance of the magnum of
pretreated chicks is shown in Figs . 3 a and b. In
spite of extensive involution of the tissue as shown
in Fig. 1, the magnum retains its original con-
figuration including a well-defined outer muscle
layer and an inner epithelium. The area between
FIGURES 9 a and b Histology of magnum of chicks treated daily with estrogen for 10 days . 2 a, X 18; 9 b,
X 510.
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127FIGURES 3 a and b Histology of magnum of chicks treated initially with estrogen for 10 days and then
untreated for 12 subsequent days. 3 a, X 25; 3 b, X 360.
the epithelial and serosal surfaces is still occupied
by tubular gland cells and accompanying stromal
cells. Most tubular gland cells retain their acinar
pattern, whereas others appear to form cell clumps .
However, in contrast to Fig. 2 b, the cells are small
in size and the eosinophilic granules which form-
ally constituted the bulk of tubular gland cells,
as well as the bulk of the magnum mass, are absent .
Thus, the histological findings are consistent
with the biochemical data in demonstrating that
tubular gland cell function requires the continuous
presence of estrogen. Furthermore, it appears that
progesterone administration can substitute for
estrogen in the maintenance of the function of
tubular gland cells. After hormone withdrawal,
however, tubular gland cells per se persist, as evi-
denced by the disproportionate lack of decrease in
DNA content compared to tissue weight, lysozyme,
and RNA contents as well as by the histological
findings.
The responsiveness of the pretreated oviduct,
which contains nonfunctioning tubular gland cells,
was examined with respect to combinations of
estrogen and progesterone. For comparison, chicks
which received no prior hormone treatment were
treated in the same way. As shown in Figs. 4 a and
b, during 6 days of estrogen treatment, the wet
weight and lysozyme content of the pretreated ovi-
duct increase rapidly, whereas the characteristic
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lag in the increase in both tissue weight and lyso-
zyme content (6) was observed with the immature
oviduct of previously untreated chicks. Further-
more, combined estrogen-progesterone treatment
of pretreated chicks increases the tissue weight and
lysozyme content to almost the same extent as
does estrogen treatment. In contrast, such com-
bined treatment of untreated chicks reduces the
estrogen-induced increase in tissue weight and
essentially abolishes the increase in lysozyme con-
tent as reported previously (6) . 6 days of treatment
with progesterone, which evokes little response in
the oviduct of untreated chicks, increases both the
tissue weight and lysozyme content of the pre-
treated oviduct.
Changes in DNA, RNA, and protein content
during the above experiment are shown in Table
I. In the pretreated oviduct, 6 days of estrogen
treatment result in more than a sixfold increase in
total DNA content. Progester; ne administered
alone for 6 days increases total DNA content only
1 .5-fold and, when administered with estrogen,
antagonizes the estrogen-induced increase in total
DNA content. In the untreated oviduct, 6 days of
treatment with estrogen increases total DNA con-
tent more than 22-fold, whereas treatment with
progesterone increases total DNA content just
over twofold. In addition, concomitant adminis-
tration of progesterone with estrogen markedly1 .0
L1J
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U
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FIGURES 4 a and b Comparison of changes in (a) wet weight and (b) lysozyme content in magnum of
immature and estrogen-pretreated chicks . One group of 926-day-old chicks, treated previously with
estrogen (1 mg/hick/day) for 10 days and subsequently untreated for 19 days, was treated daily with
either 1 mg of estradiol 17(3-benzoate (E, •	0), or progesterone (P, A - A), or both (EP,
0---.) for 6 days. Another group of chicks of the same age that had received no prior hormone treat-
ment were also treated with either estradiol 17(3-benzoate (E, 0 0), or progesterone (P, L L),
or both (EP, D	O) for 6 days at the same dose of hormone as the pretreated chicks . Each point
represents the means f SEM of three chicks.
antagonizes the estrogen-induced increase in total
DNA content, resulting in a sevenfold increase in
6 days. Total RNA and protein contents of the
pretreated oviduct after 6 days of estrogen treat-
ment increase about 13- and 19-fold, respectively,
whereas in the untreated immature oviduct, such
increases are much greater following 6 days of
estrogen treatment. 6 days of treatment with pro-
gesterone result in a twofold increase in total RNA
content of both pretreated and untreated oviducts,
but the RNA/DNA ratio is somewhat higher in the
pretreated oviduct than in the untreated oviduct .
The increase in total protein content is also greater
in the pretreated oviduct, amounting to a fivefold
increase, whereas a threefold increase is found in
the immature oviduct. Combined treatment with
estrogen and progesterone increases both total
RNA and protein contents about 12-fold in the
pretreated oviduct, whereas this treatment mark-
edly reduces the estrogen-induced increase in
both total RNA and protein content in the un-
treated oviduct,
The results of Fig . 4 and Table I, then, demon-
strate that the pretreated oviduct responds rapidly
to estrogen, and furthermore, that it is also re-
sponsive to progesterone administration . In our
previous reports (5, 6), we presented evidence in-
dicating that accumulation of lysozyme in the
immature oviduct first requires the formation of
tubular gland cells, a process evoked by estrogen
administration. Furthermore, concomitant ad-
ministration of progesterone antagonizes this
process and, therefore, prevents the estrogen-
induced increase in lysozyme content (see also
Figs. 4 a and b). That new DNA synthesis is
required for the estrogen-induced increase in
lysozyme in the immature oviduct is supported
by the results of Table II. In these experiments,
we have used hydroxyurea as an inhibitor of
DNA synthesis. A considerable body of experi-
mental evidence indicates that this compound
inhibits DNA synthesis in various animal tis-
sues by inhibiting nucleotide reductase, which
converts ribonucleotides into deoxyribonucleo-
tides (21-24). As shown in Table II, concomitant
administration of hydroxyurea with estrogen in-
hibits the estrogen-stimulated incorporation of
thymidine-3H into DNA by 90% and, further-
more, antagonizes the estrogen-induced increase in
wet weight, total DNA, and lysozyme content
OKA AND ScnIMKE Hormone Interaction in Oviduct Development
	
129TABLE I
Comparison of Changes in DNA, RNA, and Protein in the Magnum of the Immature and the Estrogen -Pretreated
Chick During Treatment with Estrogen, Progesterone, and Estrogen-Progesterone
* 26-day-old chicks received no prior hormone treatment .
$ 26-day-old chicks received daily estrogen treatment (1 mg estradiol 17/3-benzoate/chick) for 10 days
and subsequently remained untreated for 12 days .
Control, no hormone treatment ; E3 and E6, 3 and 6 days after daily treatment with estradiol 170-benzoate
(1 mg/day/chick) ; EP3 and EP6, 3 and 6 days after daily treatment with both estradiol 17/3-benzoate
(1 mg/day/chick) and progesterone (1 mg/day/chick) ; P3 and P6, 3 and 6 days after daily treatment
with progesterone (1 mg/day/chick) . Each value represents the mean ± SEM of four chicks.
when given continuously for 5 days. However,
when hydroxyurea administration is started 2 days
after the daily administration of estrogen, at a
time when essentially no lysozyme is yet detect-
able (Fig. 1), then lysozyme activity is detectable
after 5 days of total treatment . These results, then,
indicate that in the immature oviduct the appear-
ance of lysozyme requires DNA synthesis, pre-
sumably for the formation of tubular gland cells .
When estrogen is administered for 2 days prior to
inhibition of DNA synthesis by hydroxyurea, a
certain number of potential tubular gland cells
have been formed as evidenced by the increase in
total DNA content. However, they do not function
in lysozyme synthesis until sometime later. Con-
comitant administration of hydroxyurea does not
inhibit the effect of estrogen to stimulate the func-
tion of tubular gland cells once such cells are
formed. Thus the effect of hydroxyurea is analo--
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gous to that of progesterone, as described pre-
viously (5, 6) .
The effect of hydroxyurea to prevent the estro-
gen-stimulated increase in lysozyme in the imma-
ture oviduct is to be contrasted to its effect on the
pretreated oviduct (Table III) . Administration of
estrogen to pretreated chicks results in a twofold
increase in oviduct wet weight, a sixfold increase
in total lysozyme, and a 50-fold increase in thymi-
dine-3H incorporation into DNA as determined at
24 hr after the treatment. Hydroxyurea adminis-
tration inhibits the estrogen-stimulated DNA syn-
thesis by 90% but has essentially no effect on the
increase in wet weight or lysozyme content. Pro-
gesterone administration produces comparable
effects on increases in wet weight and total lyso-
zyme content although its effect on DNA synthe-
sis, as judged by the thymidine-3H incorporation,
is only 12-fold. The increases in wet weight and
Treatment DNA DNA
mg/g magnum
wet weight
RNA
pg/magnum
RNA
mg/g magnum
met weight
RNA/
DNA Protein
mg/magnum
Protein
µg/magnum mg/g magnum
wet weight
Immature
oviduct*
Control 6.4±0.4 7 .0±0 .2 1 .1 0 .94±0 .3 78±2 77±5 84±8
E 3 655 ± 10 3 .1 ± 0.2 2030 ± 31 9 .6 ± 0 .2 3 .1 18 .9 ± 1 .5 89 ± 4
E 6 1780 ± 35 2 .6 ± 0 .2 7150 ± 28 10.5 ± 0 .3 4 .0 119 .0 ± 2 .5 175 ± 6
EP 3 346 ± 9 2 .3 ± 0 .1 730 ± 15 4.7 ± 0 .1 2 .1 13 .3 ± 1 .5 89 ± 7
EP 6 560 ± 12 1 .9 ± 0.2 1160 ± 22 4 .4 ± 0 .3 2 .3 20 .9 ± 1 .7 103 ± 5
P 3 102 ± 4 6 .0 ± 0.2 120 ± 7 7 .2 ± 0 .3 1 .2 1 .5 ± 0 .2 92 ± 3
P 6 162 ± 5 6 .0 ± 0 .1 210 ± 8 7 .8 ± 0 .2 1 .3 2 .7 ± 0 .4 99 ± 3
Pretreated
oviduct l
Control 600 ± 18 6 .5 ± 0 .3 870 ± 25 9 .4 ± 0 .1 1 .5 13 .7 ± 1 .2 148 ± 7
E 3 2900 ± 38 4.2 ± 0 .1 10100 ± 59 14 .6 ± 0 .3 3.2 92 .0 ± 2 .1 133 ± 5
E 6 3240 ± 51 2.7 ± 0.3 12000 ± 78 12 .4 ± 0 .2 3 .6 248 .0 f 2 .8 207 ± 10
EP 3 2020 ± 60 3 .7 ± 0 .2 6000 ± 75 10 .5 ± 0 .3 2 .8 75 .5 ± 1 .9 132 ± 9
EP 6 2720 ± 41 2 .9 ± 0 .2 10000 ± 67 10 .9 ± 0 .2 3 .6 172 .0 ± 2.2 186 ± 11
P 3 1050 ± 61 5 .4 ± 0 .3 2060 ± 51 10 .6 ± 0 .1 2 .0 36 .7 ± 1 .4 137 ± 7
P 6 961 ± 55 4.0 ± 0.1 1930 ± 58 8 .3 ± 0 .2 2 .2 72 .6 ± 1 .8 148 ± 12TABLE II
Effect of Hydroxyurea on Changes Induced by Estrogen in the Immature Oviduct
* 4-day-old immature chicks were administered estradiol 1713-benzoate daily at a dose of 1 mg/chick.
$ DNA synthesis was measured at 24 hr after the first treatment. Details are described in Materials and
Methods.
§ Hydroxyurea (HU) was injected subcutaneously every 12 hr at a dose of 400 mg/100 g body weight .
Each value represents the mean t SEM of three chicks.
TABLE III
Effect of Hydroxyurea on Changes Induced by Estrogen, Progesterone, and Their Combination
in the "Pretreated" Magnum*
* 4-day-old chicks were initially treated daily with a dose of 1 mg estradiol 17/3-benzoate for 10 days and
thereafter remained untreated for 12 days. Chicks were then treated with 1 mg of either estradiol 170-
benzoate, or progesterone, or both for 24 hr.
t The extent of ovalbumin and protein synthesis was measured in vitro as described in Materials and
Methods. Protein synthesis was measured in 105,000 g supernatant fraction. Each value was obtained
from two chicks.
§ The extent of DNA synthesis was measured at 24 hr after treatments as described in Materials and
Methods. Each value represents the mean t SEM of three chicks.
11 Hydroxyurea (HU) was injected subcutaneously at a dose of 400 mg/100 g body weight at 0 and 12 hr
after hormone treatment .
** Hydroxyurea (HU) was injected subcutaneously at a dose of 400 mg/100 g body weight at 0, 6, 12, and
18 hr after estrogen treatment.
lysozyme content produced by progesterone are lysozyme content somewhat more than does estro-
not affected by hydroxyurea, although hydroxy- gen or progesterone separately . However, the
urea inhibits the progesterone-induced DNA syn- estrogen-induced DNA synthesis is inhibited by
thesis. Combined administration of estrogen and concomitant administration of progesterone by
progesterone increases the wet weight and total 40% . Hydroxyurea inhibits DNA synthesis by
OKA AND SCHIMKE Hormone Interaction in Oviduct Development
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Treatment
Magnum
wet weight
Total lysozyme
in magnum
Ovalbumin$
synthesis
Protein$
synthesis
DNA§
synthesis
mg µg cpm X 10 -s/g wet weight cpm X 10/mg DNA
Control 119 t 3 8 .0 f 0 .1 92, 88 1195, 1060 50 f 3
Estrogen 233 f 6 48 .7 f 0 .5 8500, 10400 14400, 17650 2620 f 28
Estrogen + HUJJ 206 zh 9 47 .2 f 0 .2 11675, 10900 25400, 23200 253 t 11
Estrogen + HU** 191 f 7 47 .3 f 0 .1 135 f 13
Progesterone 229 f 5 44 .7 f 0 .2 5050, 4600 11000, 10000 602 f 19
Progesterone + HUJJ 207 f. 7 46 .7 f 0 .4 5310, 5400 10000, 9500 252 f 15
Estrogen + progesterone 263 f 7 50.6 f 0.5 9800, 9680 20000, 19700 1497 f 36
Estrogen-{- progesterone + 212 f 8 48.7 f 0.2 9850, 9950 18200, 19500 236 f 13
HU 11
Treatment*
Magnum
wet weight
Total lysozyme
in magnum
Total DNA
in magnum t DNA synthesis
Control 13
mg
t 2
µg
undetectable
µg
40 f 5
cpm/mg DNA
40 f 2
Estrogen 3 days 63 f 7 3 .2 f 0 .2 182 t 6
Estrogen 5 days 162 f 11 59.5 f 1 .5 492 f 15 450 t 15
Estrogen + HU§ 5 days 33 f 5 <0 .9 95 f 9 52 f 5
Estrogen 2 days + estrogen + 103 ± 9 18.7 f 0 .8 139 f 6
HU§ 3 days85% but has essentially no effect on the increase
in wet weight and total lysozyme content resulting
from the combined treatment. Also of interest are
the effects of these hormones and their combination
on ovalbumin synthesis. All of the hormone treat-
ments increase markedly the capacity of oviduct
minces to incorporate amino acids into ovalbumin
as well as total soluble protein . In addition, a com-
parison of radioactivity incorporated into oval-
bumin and total soluble protein indicates that
ovalbumin is a major protein being synthesized
in oviduct after the above hormone treatment,
amounting to about 50% of total soluble protein.
In these experiments, progesterone appears to be
less active than estrogen in stimulating ovalbumin
synthesis, whereas in other experiments pro-
gesterone has been found to be at least as active
as estrogen during the first 12 hr period after the
hormone treatment (see Fig. 7). Treatment with
hydroxyurea does not inhibit such hormone-in-
duced increases in ovalbumin and protein synthe-
sis. These results, then, indicate that at 24 hr after
the administration of estrogen, progesterone, or
their combination to pretreated chicks, the syn-
thesis of lysozyme and ovalbumin is already stimu-
lated markedly and, furthermore, does not require
new DNA synthesis.
FIGURE 5 Histology of magnum of the pretreated
chicks 12 hr after estrogen administration . 4-day-old
chicks were initially treated daily with a dose of
l mg of estradiol 17,3-benzoate for 10 days and there-
after remained untreated for 12 days. The chicks were
then given another injection of estrogen (1 mg/chick),
and 1Q hr later the tissue was fixed . X 360.
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FIGURE 6 Comparison of dose-response relationship of
estrogen and increase in wet weight and lysozyme
activity in magnum of immature and estrogen-pre-
treated chicks. 26-day-old chicks were treated with the
indicated dose of estradiol 17,3-benzoate for 5 days.
Another group of chicks of the same age which had
received 10 days of estrogen treatment and thereafter
was untreated for 12 days was also treated with the
indicated dose of estradiol 17,3-benzoate for 5 days.
Results are presented as increase in magnum wet
weight (immature oviduct, • •; pretreated ovi-
duct, 0 0) and lysozyme content per gram of
magnum wet weight (immature oviduct, N- . AN;
pretreated oviduct, O- - -0) after 5 days of daily
treatment. Each point represents the means t SEM
of four chicks.
The rapid nature of the response of the pre-
treated oviduct to estrogen is also indicated by
histological examination of the oviduct at 12 hr
after the administration of estrogen to pretreated
chicks. As shown in Fig . 5, essentially all of the
tubular gland cells have increased cytoplasmic
volumes, and characteristic eosinophilic granules
are present in their apical region in contrast to
control pretreated oviduct (Fig. 3 b) . Similar
changes in histology of the oviduct are seen when
pretreated chicks are given progesterone or a com-
bination of estrogen and progesterone for 12 hr.
The difference in responsiveness of the magnum
between the immature oviduct and the pretreated
oviduct which contains nonfunctioning tubular
gland cells is further indicated by the differencesx
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FIGURE 7 Comparison of dose-response relationship
of estrogen, progesterone, and their combination with
respect to ovalbumin synthesis in magnum of estrogen-
pretreated chicks. 26-day-old chicks which had received
10 days of estrogen treatment and thereafter were
untreated for 12 days were given the indicated dose of
either estradiol 17(3-benzoate (01 ), or progesterone
((), or both ( ) for 12 hr. Control chicks received
sesame oil only ( ) . The extent of ovalbumin synthesis
was measured in vitro as described in Materials and
Methods. Each column represents the means f SEM
of three determinations.
in the dose of estrogen required to produce an
increase in wet weight and lysozyme content . As
shown in Fig. 6, the dose of estrogen necessary to
elicit an increase in wet weight and lysozyme con-
tent is much less in the pretreated oviduct than in
the immature oviduct. This is particularly ap-
parent with respect to lysozyme content ; a dose
of 0.1 mg/day evokes essentially no lysozyme
increase in the immature oviduct, whereas as little
as 0.01 mg/day produces a significant increase in
lysozyme in the pretreated oviduct .
The specificity of hormones evoking the rapid
oviduct responses in pretreated chicks is evaluated
in Table IV. Among the steroid hormones studied,
only estrogen (estradiol 17$-benzoate) and pro-
gesterone are effective in inducing the increase in
wet weight and total lysozyme content. Since
progesterone is known to be a precursor of various
steroid hormones in mammals including androgens
and estrogens (25), the possibility arises that pro-
1
gesterone could be acting by metabolic conversion
to an androgenic or estrogenic steroid(s) such as
testosterone, estradiol-17$, estriol, or estrone. This
possibility, however, would not seem likely since
androstanedione, a steroid which is an inter-
mediate on the pathway from progesterone to
testosterone and thence to estradiol-17$ (26), is
inactive as is testosterone itself. Furthermore, two
synthetic progestins, medroxyprogesterone and
norethindrone, are also active. These results, then,
suggest strongly that the pretreated oviduct is re-
sponsive to both estrogen and progesterone .
Some preliminary attempts have been made to
clarify the mode of action of estrogen and proges-
terone, both of which stimulate the synthesis of
lysozyme and ovalbumin in the pretreated oviduct .
In order to examine whether their effects are addi-
tive or synergistic, the effect of various dosages of
estrogen and progesterone and their combination
has been studied on ovalbumin synthesis at 12 hr
after the hormone treatment . Results shown in
Fig. 7 indicate that the increase in ovalbumin syn-
thesis becomes greater with increasing doses of
both hormones. A dose of 1-2 mg appears to be
the near maximal dose of both estrogen and pro-
testerone. At all the dosages tested, however, pro-
TABLE IV
Effect of Various Steroid Hormones on Wet Weight
and Lysozyme Content in the Magnum of Pretreated
Chicks*
* 4-day-old immature chicks were initially treated
with 1 mg of estradiol 17$-benzoate daily for 12
days and remained untreated for 10 days .
$ Each hormone was administered intramuscularly
at a dose of 1 mg/chick .
Each value was obtained 24 hr after the hormone
treatment and represents the mean f SEM of three
chicks.
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Treatment$
Magnum
wet weight
Total lysozyme
in magnum
mg Ag
Control 208 f 4 12 .0 f 0.8
Estradiol 17$-benzoate 366 f 18 51 .3 f 0 .7
Progesterone 367 f 11 50 .0 f 0 .5
Norethindrone 467 f 35 59 .5 f 0 .9
Medroxyprogesterone 311 f 25 30 .7 f 0 .3
Testosterone 233 f 10 15 .7 f 0 .7
Androstanedione 234 f 20 13 .8 f 0 .6
Hydrocortisone
21-phosphate
200 f 3 11 .4 f 0 .6
Deoxycorticosterone 170 f 2 11 -1 f 0.2gesterone appeared to be more potent than estro-
gen. Combined administration of both estrogen
and progesterone at a dose of 0 .05 mg, which pro-
duces the minimal increase, stimulates ovalbumin
synthesis far greater than does separate adminis-
tration of estrogen or progesterone at an equivalent
dose of 0.1 mg. At the near maximal dose of the
two hormones, combined treatment produces still
greater increase, although the difference between
combined and single hormone treatment becomes
smaller. Such a synergistic effect suggests that
estrogen and progesterone may stimulate oval-
bumin synthesis by somewhat different mecha-
nisms.
DISCUSSION
Our present conception of the effect of estrogen
and/or progesterone on tubular gland cell forma-
tion and function is outlined in Fig. 8. Initiation of
tubular gland cell proliferation from the surface
epithelium commences within 24 hr of the initial
estrogen treatment. However, such cells become
functional in the synthesis of lysozyme and oval-
bumin only after 2-3 days of estrogen treatment.
Tubular gland cell function is dependent on the
continuous presence of estrogen since its discon-
tinuation results in a rapid cessation of function
and oviduct involution which is accompanied by
the loss of tissue weight and total lysozyme and
RNA content. However, tubular gland cells per
se persist during such involution .
The response of the oviduct containing non-
functioning tubular gland cells (the pretreated
oviduct) to estrogen treatment is to be contrasted
with that of the immature oviduct. In the pre-
treated oviduct, estrogen evokes an increase in
lysozyme and ovalbumin within 12 hr of treatment,
Stromal Epithelial
ce//s
~m
Kcells Ep
Immature Oviduct
Epithelial diCrer-
entiation
ciliated cells
goblet cells
E
Functioning
tubular gland
cells
EP/thelia/
d diPrer-
entiation
a process which is not dependent on new DNA syn-
thesis. In the immature oviduct, the appearance
of lysozyme is detectable only after 2-3 days of
treatment and is prevented by inhibition of DNA
synthesis by hydroxyurea. In addition, a larger
dose of estrogen appears to be necessary for an
increase in lysozyme in the immature oviduct
compared to the pretreated oviduct . These differ-
ences can be attributed to the fact that the pre-
treated oviduct contains tubular gland cells which
are capable of responding rapidly to estrogen with
the synthesis of lysozyme and ovalbumin . Pre-
liminary data3 indicate that an increase in lyso-
zyme and ovalbumin synthesis occurs as early as
3-4 hr after estrogen treatment . In the immature
oviduct, in contrast, tubular gland cells are absent,
and therefore the synthesis of lysozyme and oval-
bumin must be preceded by the formation of tubu-
lar gland cells, a process which is prevented by
inhibition of DNA by hydroxyurea .
The effect of progesterone administration differs
markedly at different stages of oviduct develop-
ment. In the immature oviduct, progesterone ad-
ministration results in no increase in lysozyme but
antagonizes the effect of estrogen to induce the
increase in lysozyme by preventing the formation
of tubular gland cells when given concomitantly
with estrogen. Once tubular gland cells are pres-
ent, i.e. 4-5 days after estrogen treatment, proges-
terone can substitute for estrogen in maintaining
the function of tubular gland cells . Kohler et al.
(4) have reported that continued estrogen treat-
ment stimulates the mitosis associated with tubular
gland cells (glandular mitosis, see Fig. 8) in addi-
tion to the appearance of epithelial goblet and
ciliated cells. We do not know if progesterone
stimulates mitosis in tubular gland cells . Proges-
Synthesis LPlysozyme
and ovalbumin by
tubular gland
cells
Eor -Epithelia) E}
mitosis, budding,
&Formation oP glandular
ubularglandcells
	
mitosis
Estrogen 1-4dags Estrogen 5-8 days
Non Functioning
tubular
gland
cells
Resumption of
synthesis ac Iysozyme
and ovalbumin
by tubular
gland cells
Restimulation by
Estrogen to days Estrogen withdrawal
	
Estrogen
10-21 days
	
12-24hr
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FIGURE 8 Summary of estrogen-
progesterone interactions in the devel-
opment and function of the tubular
gland cells in chick oviduct. E,
estrogen; P, progesterone; EP, estro-
gen plus progesterone.terone appears to enhance morphological differen-
tiation of surface epithelial cells when it is ad-
ministered alone or with estrogen, as opposed to
its antagonistic effect on the initiation of tubular
gland cell formation.
Perhaps most striking is the finding that adminis-
tration of progesterone stimulates the synthesis of
lysozyme and ovalbumin in tubular gland cells
which previously were not functioning (Fig . 8) .
Such effects of progesterone are to be compared
and contrasted with the findings of O'Malley and
his coworkers who have shown that progesterone
stimulates avidin synthesis in goblet cells (7-11) .
Initiation of avidin synthesis by progesterone (26)
does not require new DNA synthesis in goblet
cells. This is similar to the effect of progesterone
on lysozyme and ovalbumin synthesis in preexist-
ing tubular gland cells. However, in avidin syn-
thesis only progesterone and its analogues are
effective (8), whereas in lysozyme and ovalbumin
synthesis both estrogen and progesterone are
effective. Such diverse effects of progesterone as
well as estrogen on a single tissue suggest differ-
ences in competence of various cell types in that
tissue to respond to a hormonal stimulus . Thus, in
the study of this system (or of any system, for that
matter) care must be taken in interpreting bio-
chemical results where little attempt has been
made to consider different responses among various
cell types.
The effects of estrogen and progesterone in the
oviduct illustrate two general types of hormonal
responses commonly observed . The first response
is characterized by cell proliferation leading to
the acquisition of cells that engage in a specific
function. Thus, estrogen evokes the appearance
of new cell types, among which are tubular gland
cells that can synthesize lysozyme and ovalbumin,
goblet cells that can synthesize avidin under ap-
propriate hormonal stimulation, as well as ciliated
epithelial cells. The results with hydroxyurea in
the immature oviduct (Table II) indicate that
DNA synthesis is necessary for cells to acquire the
ability to respond to estrogen with the synthesis
of lysozyme. In this respect, then, the system is
similar to that studied by Topper and his collabo-
rators who have shown that, in cultured mouse
mammary gland tissue, the effect of prolactin to
accelerate casein synthesis requires new DNA syn-
thesis and mitosis of epithelial cells, a process that
is stimulated by insulin and requires the presence
of hydrocortisone (27). In addition, androgens
appear to inhibit new casein synthesis by inhibit-
ing the insulin-mediated new DNA synthesis (28) .
Thus, this effect of androgens appears to be com-
parable to the effect of hydroxyurea and/or pro-
gesterone in the immature oviduct. The apparent
requirement for DNA synthesis in the acquisition
of the ability of oviduct epithelial cells to respond
to estrogen with the synthesis of ovalbumin and
lysozyme appears to be similar to that require-
ment as observed in a number of differentiating
systems. It has been suggested (27, 29) that a cell
can be programmed for a new set of cell functions,
such as the synthesis of specific proteins, only at the
time of DNA synthesis .
The second type of response involves the stimu-
lation of function of preexisting cells as observed in
the pretreated oviduct . Other examples exist in
which the stimulation of synthesis of specific cell
proteins does not appear to require new DNA syn-
thesis but does require the continued presence of
the hormone. Among such examples are the hy-
drocortisone-mediated increased rate of synthesis
of tyrosine aminotransferase in rat liver (30) and
in cultured hepatoma cells (31, 32) and the stimu-
lation of avidin synthesis by progesterone in the
estrogen-primed chick oviduct (7-I1). In these
cases the competent cells are already present, and
the hormones can be considered to "switch on"
cell function in previously programmed cells .
The interaction of estrogen and progesterone is
obviously complex in oviduct development . With
respect to the initiation of tubular gland cell for-
mation, progesterone is antagonistic to estrogen .
As previously reported (6), progesterone does not
inhibit either the absorption of estrogen from the
injection site or the uptake of estrogen into the
tissue. One simple hypothesis that progesterone
simply displaces estrogen from the specific receptor
site(s) seems unlikely, inasmuch as increasing the
dose of estrogen does not overcome the proges-
terone antagonism. In addition, the antagonism
appears to be tissue specific since the estrogen-in-
duced synthesis of phosvitin in liver is not in-
hibited by progesterone administration. At the
present time, we do not know how progesterone
produces its antagonistic effect. Clearly, the events
leading to cell proliferation are complicated and
may require a sequence of preceding events. Thus,
progesterone may exert its inhibitory effect by
preventing one of a number of events that occur
prior to the increase in DNA synthesis which com-
mences only 8-12 hr after estrogen administration.3
Such events include stimulation of RNA synthesis 3
accompanied by increased RNA polymerase ac-
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135tivity (33), migration of circulating monocytes
into the tissue (4), and increased uptake of water
and amino acids, the latter of which are not in-
hibited by progesterone (6) . One other possible
mechanism of progesterone antagonism relates to
its effect to produce epithelial differentiation.
Thus, one might propose that progesterone induces
undifferentiated epithelial progenitor cells into
specifically differentiated epithelial cells, and that,
once differentiated, such cells are no longer avail-
able for differentiation into tubular gland cells.
It is also possible that progesterone antagonism
may be mediated through complex effects on the
metabolism of other hormones, since all the ex-
perimental evidences have been obtained from the
intact chick. A report on the Corturnix quail by
Brody and Zarrow (34) indicates that ovariectomy
diminishes the effect of prolactin, but not that of
progesterone, in stimulating the estrogen-induced
oviduct growth.
In contrast to its antagonistic effect on tubular
gland cell formation, progesterone can stimulate
function once such cells exist . Several explanations
can be envisaged for this effect. Since all the ex-
periments have been performed in the intact chick,
the possibility exists that progesterone is converted
to an estrogenic steroid which is the active agent .
We have no conclusive proof against such a theory,
particularly since we do not know whether the
hormone is active as itself, or as a metabolite . Two
lines of evidence suggest that metabolic conversion
from progesterone to estrogen does not account for
the action of progesterone on tubular gland cell
function. Thus, steroid compounds that one would
presume to be intermediates as judged by studies
in mammals (25), i.e. androstanedione and testos-
terone, are not effective in initiating the synthesis
of lysozyme, whereas synthetic progestational
steroids are equally active. Furthermore, the
effects of estrogen and progesterone appear to be
different in that progesterone stimulates mainly
cell function, whereas estrogen stimulates both
cell proliferation and function (Tables I and IV) .
In addition, progesterone is more potent than
estrogen during a short period after hormone ad-
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ministration, i.e. 12 hr, while estrogen produces a
greater increase in lysozyme and ovalbumin at
later time intervals (Figs. 2 and 7; Table IV). Per-
haps most striking is the apparent synergistic
effect of estrogen and progesterone on ovalbumin
synthesis (Fig. 7) . Thus, whereas low doses of
either estrogen or progesterone produce minimal
effects on ovalbumin synthesis, a combination of
the two hormones produces nearly maximal stimu-
lation of ovalbumin synthesis. Such a finding sug-
gests that the two hormones may be acting in a
slightly different fashion to stimulate cell function .
Further studies are in progress to clarify the mode
of action of estrogen and progesterone and to
identify the active form of each steroid hormone in
this system.
The pretreated oviduct, with a large number of
nonfunctioning tubular gland cells, is a good sys-
tem for the study of hormonal regulation of specific
protein synthesis. This system is characterized by
the presence of a specific cell type which synthe-
sizes well-characterized proteins, including lyso-
zyme and ovalbumin. Ovalbumin amounts to as
much as 50% of the total soluble proteins synthe-
sized, and its synthesis is rapidly initiated by
treatment with two different steroid hormones
which may act through somewhat different mecha-
nisms. The studies presented to date have been
descriptions of over-all events and hopefully will
form the basis of a better understanding of bio-
chemical and macromolecular events in tubular
gland cells as affected by estrogen and proges-
terone. Thus, dissection and comparison of their
effects in this system may provide useful knowledge
in understanding hormonal control of protein
synthesis.
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